Diet and lifestyle study for liver health in people with HIV
Part of Digestive system, Immune system & allergy, Infections clinical trials.
This study looks at how diet and lifestyle affect liver health and heart risk in people with HIV. It may help find ways to prevent or manage liver fat buildup.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have HIV (whether you take HIV medicines or not) or you do not have HIV
- You do not drink more than a small amount of alcohol (for men: up to 2 drinks a day; for women: up to 1 drink a day)
- You are not pregnant
- You have no current or past cancer and no advanced liver cirrhosis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at liver health in people newly diagnosed with HIV, before they start HIV treatment. It aims to understand early changes in the liver related to metabolism.
This study looks at fat buildup in the liver (fatty liver disease) in people with and without HIV. It uses blood tests to understand the liver's fat content and how it relates to HIV, which may help improve future care.
This trial tests a digital lifestyle program (diet and activity coaching) to help people with HIV and fatty liver disease lose weight. It aims to see if the program can reduce body fat in the liver and improve overall health.
This study tests whether adding a liver stiffness measurement to a lifestyle program helps people with MASLD (a type of fatty liver disease) improve their liver health. It is designed for people who have fatty liver and at least one sign of metabolic syndrome, like high blood pressure or diabetes.
This study follows people with HIV who also have fatty liver disease and checks their health over time. It may help by improving monitoring and care planning, especially using ultrasound scans and regular follow-up.
This study tests if resmetirom can help people who have both HIV and a liver condition called MASLD (fat buildup in the liver not caused by alcohol). You may qualify if your liver has a certain amount of fat and stiffness, and your HIV is well controlled with stable medication.
Hear when a new HIV Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.